The Christie charity
The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for T-Cell lymphoma patients.
If you would like to know how to access our trials please click here
|
Trial Name |
Description |
Click the link for more information (external page) |
|
RESMAIN |
Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.
|
|
|
PROCLIPI |
A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.
|
|
|
SGN35-032 |
A phase 2 trial of brentuximab vedotin plus chemotherapy in people with peripheral T-cell lymphoma.
|
|
|
PRIMO |
A phase 2 trial of duvelisib in people with relapsed or refractory peripheral T cell lymphoma.
|
|
With special thanks to the following:
